Yuefen Zhou Selected Research

Yuefen Zhou Research Topics

5	Neoplasms (Cancer) 02/2024 - 06/2019
1	Vomiting 01/2023
1	Nausea 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Breast Neoplasms (Breast Cancer) 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Pain (Aches) 06/2019
1	Cancer Pain 06/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Osteochondroma (Osteocartilaginous Exostosis) 01/2018
1	Ductal Carcinoma 01/2017
1	Escherichia coli Infections 12/2005
1	Body Weight (Weight, Body) 12/2005

2	penpulimabIBA 02/2024 - 10/2022
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	Aprepitant (Emend)FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	fosaprepitant FDA Link 01/2023
1	AntiemeticsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 10/2022
1	Immunoglobulin G (IgG)IBA 10/2022
1	isothiocyanic acidIBA 01/2020
1	cyanoginosin LR (microcystin LR)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2020
1	napabucasinIBA 11/2019
1	Estrogen ReceptorsIBA 11/2019
1	Tamoxifen FDA LinkGeneric 11/2019
1	Anaplastic Lymphoma KinaseIBA 10/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 06/2019
1	Morphine (MS Contin)FDA LinkGeneric 06/2019
1	Opioid Analgesics (Opioids)IBA 06/2019
1	TabletsIBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2017
1	LigandsIBA 01/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2005

1	Therapeutics 02/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Bite Force (Occlusal Forces) 01/2023
1	Intravenous Administration 12/2005